Roberts Pharmaceutical, Bristol-Myers deal

Roberts acquired Agrylin, a platelet reducing drug that it has marketed since 1997, from Bristol-Myers. Roberts made an upfront cash payment equal to one times estimated 1999 Agrylin sales, which Rob...